RSS-Feed abonnieren
DOI: 10.1055/s-2007-967984
Transition Metals in Organic Synthesis, Part 82. [1] First Total Synthesis of Methyl 6-Methoxycarbazole-3-carboxylate, Glycomaurrol, the Anti-TB Active Micromeline, and the Furo[2,3-c]carbazole Alkaloid Eustifoline-D
Publikationsverlauf
Publikationsdatum:
24. Januar 2007 (online)
Abstract
The palladium(0)-catalyzed amination followed by palladium(II)-catalyzed oxidative cyclization of the resulting diarylamine provides a short route to a series of 6-oxygenated carbazole alkaloids: glycozoline, 3-formyl-6-methoxycarbazole, methyl 6-methoxycarbazole-3-carboxylate, glycozolinine (glycozolinol), glycomaurrol, micromeline, and eustifoline-D.
Key words
alkaloids - antibiotics - catalysis - nickel - palladium
- 1 Part 81:
Krahl MP.Jäger A.Krause T.Knölker H.-J. Org. Biomol. Chem. 2006, 4: 3215 -
2a
Chakraborty DP.Roy S. In Progress in the Chemistry of Organic Natural Products Vol. 57:Herz W.Grisebach H.Kirby GW.Steglich W.Tamm C. Springer; Wien: 1991. p.71 -
2b
Chakraborty DP. In The Alkaloids Vol. 44:Cordell GA. Academic Press; New York: 1993. p.257 -
3a
Knölker H.-J.Reddy KR. Chem. Rev. 2002, 102: 4303 -
3b
Knölker H.-J. Top. Curr. Chem. 2005, 244: 115 -
4a
Pindur U. Chimia 1990, 44: 406 -
4b
Bergman J.Pelcman B. Pure Appl. Chem. 1990, 62: 1967 -
4c
Kawasaki T.Sakamoto M. J. Indian Chem. Soc. 1994, 71: 443 -
4d
Moody CJ. Synlett 1994, 681 -
4e
Hibino S.Sugino E. In Advances in Nitrogen Heterocycles Vol. 1:Moody CJ. JAI Press; Greenwich (CT): 1995. p.205 -
4f
Kirsch GH. Curr. Org. Chem. 2001, 5: 507 -
4g
Lemster T.Pindur U. Recent Res. Dev. Org. Bioorg. Chem. 2002, 5: 99 - 5
Kataeva O.Krahl MP.Knölker H.-J. Org. Biomol. Chem. 2005, 3: 3099 -
6a
Chakraborty DP.Das K.Das BP.Chowdhury BK. Trans. Bose Res. Inst. 1975, 38: 1 -
6b
Chowdhury DN.Basak SK.Das BP. Curr. Sci. 1978, 47: 490 -
7a
Chakraborty DP. Tetrahedron Lett. 1966, 661 -
7b
Chakraborty DP. Phytochemistry 1969, 8: 769 -
8a
Adesina SK.Olatunji OA.Bergenthal D.Reisch J. Pharmazie 1988, 43: 221 -
8b
Ito C.Thoyama Y.Omura M.Kajiura I.Furukawa H. Chem. Pharm. Bull. 1993, 41: 2096 - 9
Chakravarty AK.Sarkar T.Masuda K.Shiojima K. Phytochemistry 1999, 50: 1263 - 10
Rastogi K.Kapil RS.Popli SP. Phytochemistry 1980, 19: 945 - 11
Li W.-S.McChesney JD.El-Feraly FS. Phytochemistry 1991, 30: 343 - 12
Adesina SK.Olugbade TA.Akinwusi DD.Bergenthal D. Pharmazie 1997, 52: 720 -
13a
Mukherjee S.Mukherjee M.Ganguly SN. Phytochemistry 1983, 22: 1064 -
13b
Bhattacharyya P.Sarkar T.Chakraborty A.Chowdhury BK. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1984, 23: 49 - 14
Wu S.-L.Li W.-S. Chin. Pharm. J. 1999, 51: 227 - 15
Kumar V.Reisch J.Wickramasinghe A. Aust. J. Chem. 1989, 42: 1375 - 16
Ma C.Case RJ.Wang Y.Zhang H.-J.Tan GT.Hung NV.Cuong NM.Franzblau SG.Soejarto DD.Fong HHS.Pauli GF. Planta Med. 2005, 71: 261 - 17
Ito C.Furukawa H. Chem. Pharm. Bull. 1990, 38: 1548 -
18a
Chakraborty DP.Das KC.Chowdhury BK. Sci. Cult. 1966, 32: 245 -
18b
Chakraborty DP.Das KC.Chowdhury BK. Chem. Ind. 1966, 1684 -
18c
Carruthers W. J. Chem. Soc., Chem. Commun. 1966, 272 -
18d
Bhattacharyya P.Mitra AR.Chakraborty DP. J. Indian Chem. Soc. 1976, 53: 321 -
18e
Bhattacharyya P.Jash SS. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1986, 25: 1056 -
18f
Kudav DP.Kulkarni NN.Hosangadi BD. J. Chem. Res., Synop. 1994, 266 -
19a
Anwer F.Masaldan AS.Kapil RS.Popli SP. Indian J. Chem. 1973, 11: 1314 -
19b
Chowdhury BK.Saha C. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 1994, 33: 892 - 20
Iwao M.Takehara H.Furukawa S.Watanabe M. Heterocycles 1993, 36: 1483 -
21a
Fröhner W.Krahl MP.Reddy KR.Knölker H.-J. Heterocycles 2004, 63: 2393 -
21b
Knölker H.-J.Reddy KR. In Selected Methods for Synthesis and Modification of Heterocycles - The Chemistry and Biological Activity of Natural Indole Systems Part 1, Vol. 4:Kartsev VG. ICSPF Press; Moscow: 2005. p.166 -
22a
Hartwig JF. Angew. Chem. Int. Ed. 1998, 37: 2046 -
22b
Muci AR.Buchwald SL. Top. Curr. Chem. 2002, 219: 131 -
23a
Åkermark B.Eberson L.Jonsson E.Petersson E. J. Org. Chem. 1975, 40: 1365 -
23b
Miller RB.Moock T. Tetrahedron Lett. 1980, 21: 3319 -
23c
Furukawa H.Ito C.Yogo M.Wu T.-S. Chem. Pharm. Bull. 1986, 34: 2672 -
23d
Knölker H.-J.O’Sullivan N. Tetrahedron 1994, 50: 10893 -
23e
Knölker H.-J.Fröhner W.Reddy KR. Synthesis 2002, 557 -
23f
Knölker H.-J.Reddy KR. Heterocycles 2003, 60: 1049 -
23g
Knölker H.-J.Knöll J. Chem. Commun. 2003, 1170 - 24 The preparation of compound 10 using a Pd(0)-catalyzed amination has been reported previously, albeit in lower yield (77%):
Urgaonkar S.Xu J.-H.Verkade JG. J. Org. Chem. 2003, 68: 8416 - 25
Corey EJ.Gilman NW.Ganem BE. J. Am. Chem. Soc. 1968, 90: 5616 -
26a
Wilke G.Bogdanovic B.Hardt P.Heimbach P.Keim W.Kröner M.Oberkirch W.Tanaka K.Steinrücke E.Walter D.Zimmermann H. Angew. Chem., Int. Ed. Engl. 1966, 5: 151 -
26b
Corey EJ.Semmelhack MF. J. Am. Chem. Soc. 1967, 89: 2755 -
26c
Plieninger H.Sirowej H. Chem. Ber. 1971, 104: 2027 -
26d
Inoue S.Yamaguchi R.Saito K.Sato K. Bull. Chem. Soc. Jpn. 1974, 47: 3098 -
26e
Billington DC. Chem. Soc. Rev. 1985, 14: 93 - 30
Röhrkasten R.Konrad M. In Methoden der Organischen Chemie (Houben-Weyl) Vol. E6b:Kreher RP. Thieme; Stuttgart: 1994. p.94 - 33
Braxmeier T,Friedrichson T,Fröhner W,Jennings G,Schlechtingen G,Schroeder C,Knölker H.-J,Simons K,Zerial M, andKurzchalia T. inventors; PCT Int. Appl. WO 2006002908. - 34
Choi T.Czerwonka R.Fröhner W.Krahl MP.Reddy KR.Franzblau SG.Knölker H.-J. ChemMedChem 2006, 1: 812
References and Notes
Pure glycomaurrol (5) was obtained by preparative HPLC on a Vydac C8 50 mm column (gradient elution with 50 mL/min MeCN-H2O, 30-60% MeCN in 30 min).
Glycomaurrol (5): colorless crystals; mp 141 °C. UV (MeOH): λmax = 257, 269, 292 (sh), 301, 350, 362 (sh) nm. IR (ATR): ν = 3409, 3214, 2917, 1589, 1512, 1499, 1476, 1442, 1390, 1349, 1309, 1282, 1267, 1225, 1166, 1148, 1100, 1069, 1030, 954, 871, 850, 797, 739, 694, 648 cm-1. 1H NMR (500 MHz, acetone-d
6): δ = 1.72 (d, J = 1.2 Hz, 3 H), 1.98 (s, 3 H), 2.51 (s, 3 H), 4.01 (d, J = 6.5 Hz, 2 H), 5.37 (t, J = 6.5 Hz, 1 H), 7.03 (d, J = 8.5 Hz, 1 H), 7.19 (d, J = 8.5 Hz, 1 H), 7.20 (m, 1 H), 7.37 (d, J = 8.2 Hz, 1 H), 7.70 (s, 1 H), 7.95 (s, 1 H), 9.94 (br s, 1 H). 13C NMR and DEPT (125 MHz, acetone-d
6): δ = 18.34 (CH3), 21.67 (CH3), 25.83 (CH3), 26.24 (CH2), 109.21 (CH), 111.09 (CH), 115.52 (CH), 122.15 (C), 122.97 (C), 123.29 (CH), 124.05 (CH), 124.34 (C), 126.87 (CH), 127.59 (C), 131.86 (C), 136.06 (C), 140.13 (C), 148.19 (C). MS (100 °C): m/z (%) = 265 (100) [M+], 210 (71), 209 (87), 181 (14), 180 (19), 167 (9). HRMS: m/z calcd for C18H19NO [M+]: 265.1467; found: 265.1454.
Crystal data for the bromocarbazole 12: C14H10BrNO2, M = 304.14, monoclinic, space group: P21/c, a = 19.570(4), b = 8.296(2), c = 7.360(2) Å, β = 94.77(3)°, V = 1190.8(5) Å3, Z = 4, D c = 1.696 g cm-3, µ = 3.444 mm-1, T = 198(2) K, λ = 0.71073 Å, θ range: 3.13-30.00°, 29544 reflections collected, 3454 independent (R int = 0.0629), 168 parameters. The structure was solved by direct methods and refined by full-matrix least-squares on F 2; final R indices [I > 2σ(I)]: R 1 = 0.0405, wR 2 = 0.0761; maximal residual electron density: 0.598 e Å-3. CCDC-628163 contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
29Pure micromeline (6) was obtained by preparative HPLC on a Vydac C8 50 mm column (gradient elution with 50 mL/min MeCN-H2O, 30-60% MeCN in 30 min).
Micromeline (6): colorless crystals; mp 205-206 °C. UV (MeOH): λmax = 231, 252, 276 (sh), 278, 281, 295 (sh), 300, 340 nm. IR (ATR): ν = 3156, 2963, 2911, 2854, 2740, 1663, 1649, 1629, 1603, 1566, 1522, 1464, 1446, 1371, 1310, 1291, 1271, 1228, 1202, 1181, 1164, 1120, 1063, 1028, 958, 899, 883, 851, 811, 792, 717, 663 cm-1. 1H NMR (500 MHz, acetone-d
6): δ = 1.72 (d, J = 1.1 Hz, 3 H), 2.03 (s, 3 H), 4.07 (d, J = 6.4 Hz, 2 H), 5.36 (t, J = 6.4 Hz, 1 H), 7.15 (d, J = 8.5 Hz, 1 H), 7.33 (d, J = 8.5 Hz, 1 H), 7.63 (d, J = 8.5 Hz, 1 H), 7.95 (dd, J = 8.5, 1.4 Hz, 1 H), 8.03 (br s, 1 H), 8.69 (s, 1 H), 10.09 (s, 1 H), 10.70 (br s, 1 H). 13C NMR and DEPT (125 MHz, acetone-d
6): δ = 18.43 (CH3), 25.80 (CH3), 26.19 (CH2), 110.07 (CH), 111.79 (CH), 116.63 (CH), 122.76 (C), 123.26 (C and CH), 124.05 (C), 126.63 (CH), 127.40 (CH), 129.39 (C), 132.83 (C), 136.07 (C), 145.38 (C), 149.40 (C), 191.85 (CHO). MS (150 °C): m/z (%) = 279 (93) [M+], 224 (81), 223 (100), 208 (7), 195 (13), 194 (10), 183 (11), 167 (11). HRMS: m/z calcd for C18H17NO2 [M+]: 279.1259; found: 279.1262. Anal. Calcd (%) for C18H17NO2: C, 77.40; H, 6.13; N, 5.01. Found: C, 77.50; H, 6.22; N, 5.03.
Amberlyst 15 from Fluka (art. 06423).
32A separation of the two isomers 7 and 15 was achieved by preparative HPLC on a Vydac C8 30 mm column (gradient elution with 40 mL/min MeCN-H2O, 30-46% MeCN in 32 min).
Eustifoline-D (7): colorless crystals; mp 156 °C. UV (MeOH): λmax = 253, 260 (sh), 268, 298, 310, 339, 354 nm. IR (ATR): ν = 3406, 2919, 2856, 1615, 1575, 1484, 1443, 1432, 1409, 1360, 1300, 1275, 1242, 1229, 1209, 1139, 1074, 1051, 946, 886, 875, 800, 789, 780, 750, 731, 690, 659 cm-1. 1H NMR (500 MHz, CDCl3): δ = 2.59 (s, 3 H), 7.26 (dd, J = 8.3, 1.2 Hz, 1 H), 7.31 (d, J = 8.8 Hz, 1 H), 7.33 (dd, J = 2.0, 0.4 Hz, 1 H), 7.36 (d, J = 8.3 Hz, 1 H), 7.58 (d, J = 8.8 Hz, 1 H), 7.81 (d, J = 2.0 Hz, 1 H), 7.98 (s, 1 H), 8.03 (br s, 1 H). 13C NMR and DEPT (125 MHz, CDCl3): δ = 21.51 (CH3), 105.40 (CH), 107.38 (CH), 109.43 (CH), 110.43 (CH), 114.80 (C), 120.42 (C), 120.93 (CH), 123.23 (C), 126.54 (CH), 128.71 (C), 135.92 (C), 137.65 (C), 145.14 (CH), 150.27 (C). MS (20 °C): m/z (%) = 221 (100) [M+], 220 (53), 192 (7), 191 (8). HRMS: m/z calcd for C15H11NO [M+]: 221.0841; found: 221.0853. Anal. Calcd (%) for C15H11NO: C, 81.43; H, 5.01; N, 6.33. Found: C, 81.23; H, 5.07; N, 6.24.
Isoeustifoline-D (15): colorless crystals; mp 154 °C. UV (MeOH): λmax = 247, 255, 264, 272 (sh), 304, 311 (sh), 316, 349, 365 nm. IR (ATR): ν = 3403, 2918, 2854, 1617, 1533, 1504, 1483, 1446, 1342, 1326, 1307, 1292, 1262, 1220, 1175, 1154, 1125, 1097, 1030, 978, 879, 840, 799, 790, 756, 731, 697, 619 cm-1. 1H NMR (500 MHz, CDCl3): δ = 2.54 (s, 3 H), 6.83 (d, J = 2.1 Hz, 1 H), 7.24 (d, J = 8.2 Hz, 1 H), 7.28 (d, J = 8.2 Hz, 1 H), 7.47 (s, 1 H), 7.68 (d, J = 2.1 Hz, 1 H), 7.81 (br s, 1 H), 7.89 (s, 1 H), 8.10 (s, 1 H). 13C NMR and DEPT (125 MHz, CDCl3): δ = 21.39 (CH3), 100.56 (CH), 101.66 (CH), 106.53 (CH), 110.05 (CH), 120.17 (CH), 121.93 (C), 123.65 (C), 126.73 (C), 127.23 (CH), 128.34 (C), 137.38 (C), 139.00 (C), 145.65 (CH), 150.38 (C). MS (20 °C): m/z (%) = 221 (100) [M+], 220 (53), 192 (7), 191 (6). HRMS: m/z calcd for C15H11NO [M+]: 221.0841; found: 221.0851. Anal. Calcd (%) for C15H11NO: C, 81.43; H, 5.01; N, 6.33. Found: C, 80.59; H, 5.06; N, 6.15.